Rafferty Asset Management, LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1389426
New York, NY
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,656,180
-$716,375 QoQ
Shares Held
265,618
-25.0% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#86
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $21,876,011 across 22 Drug Manufacturers - Specialty & Generic names. BCRX ranks #5 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
48,590 | $3,491,677 | |
| 2 | ALKS |
Alkermes plc.
|
62,965 | $3,299,366 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
18,743 | $3,158,945 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
5,742 | $3,111,187 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
265,618 | $2,656,180 | |
| 6 | VTRS |
Viatris Inc
|
140,790 | $2,235,745 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
152,878 | $643,616 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
16,555 | $407,418 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,656,180 | 265,618 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,372,555 | 354,260 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,983,936 | 382,556 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,803,153 | 369,322 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,696,520 | 300,951 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,899,937 | 253,325 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,765,966 | 234,836 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,819,858 | 371,034 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,878,217 | 465,731 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,974,492 | 1,569,782 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,723,966 | 955,587 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,719,847 | 807,888 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,863,739 | 974,963 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,843,145 | 820,521 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,817,478 | 768,073 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,491,872 | 515,228 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,097,919 | 387,327 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,393,653 | 331,713 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,269,022 | 452,637 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,945,821 | 204,998 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,468,051 | 156,107 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,680,649 | 263,584 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $837,014 | 112,351 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,810,478 | 526,302 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,059,656 | 222,617 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $34,400 | 17,200 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||